News Releases

Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress

March 11, 2024

Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial

February 12, 2024

Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference

January 29, 2024

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

January 23, 2024

Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024

January 10, 2024

Anixa Biosciences to Present at Biotech Showcase 2024

December 14, 2023

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

December 6, 2023

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

December 6, 2023

Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology

November 27, 2023

Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference

October 31, 2023

« Previous
1
2
3
4
5
6
7
8
9
10
...29
Next »

Latest News & Events

Jun 23, 2025

Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial

Read More...

Jun 20, 2025

Anixa Biosciences to Host an Investor Webcast on June 26, 2025

Read More...

Jun 10, 2025

Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage

Read More...